Patients as experts: characterizing the most relevant patient-reported outcomes after hematopoietic cell transplantation

Bone Marrow Transplant. 2020 Jan;55(1):242-244. doi: 10.1038/s41409-019-0518-0. Epub 2019 Mar 27.

Authors

Justin C Solle¹, Alexis Steinberg¹, Priya Marathe¹, Tamryn F Gray², Amy Emmert¹, Gregory A Abel³

Affiliations

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
² Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, USA.
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. gregory_abel@dfci.harvard.edu.

PMID: 30918338
DOI: 10.1038/s41409-019-0518-0

No abstract available

Keywords: Hematopoietic cell transplantation; patient-reported outcomes; quality of life.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Diterpenes
Hematopoietic Stem Cell Transplantation*
Humans
Patient Reported Outcome Measures

Substances

Diterpenes
trans-crotonin

Grants and funding

IHS-1511-33081/Patient-Centered Outcomes Research Institute (PCORI)/International